title: Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis.
abstract: OBJECTIVE
  Susceptibility to spondyloarthritis (SpA) is largely genetically determined. To understand increasingly complex genetic associations, one approach is to study epistasis or genetic interactions. Several associations between HLA antigens and SpA including HLA-B27 have been reported. In this study, we investigated epistasis between common HLA class I risk antigens in ankylosing spondylitis (AS), the most typical form of SpA.
  
  
  METHODS
  In 154 patients with AS and 5584 controls, HLA class I antigens were analysed for association with AS. Biological interaction was analysed by investigating whether the effects of the risk factors combined departed from additivity.
  
  
  RESULTS
  Apart from the association with HLA-B27, we found an association between HLA-B60 and AS (OR 1.8; 95% CI 1.2 to 2.8). This was confirmed in a meta-analysis (OR 2.2; CI 1.8 to 2.8). While 18.2% of AS patients had both HLA-B27 and HLA-B60, this combination was found in only 0.4% of controls. Using AS patients without HLA-B27 and HLA-B60 as a reference, the relative risk (RR) for disease in HLA-B27-/HLA-B60+ patients was 1.2 (95% CI 0.3 to 4.1). For HLA-B27+/HLA-B60- the RR was 69 (95% CI 40 to 111) but increased to 342 (95% CI 147 to 708) in HLA-B27+/HLA-B60+ patients. For the interaction, the relative excess risk due to interaction was 251, the attributable proportion was 0.8 and the synergy index was 4.7. The interaction was confirmed in an independent cohort.
  
  
  CONCLUSIONS
  There is a strong epistatic interaction between HLA-B60 and HLA-B27 in AS susceptibility. As a result, individuals with the HLA-B27+/HLA-B60+ genotype are at a very high risk of developing AS.
authors.affiliation: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. f.a.van_gaalen@lumc.nl
authors.forename: Floris A
authors.initials: FA
authors.lastname: van Gaalen
authors.forename: Willem
authors.initials: W
authors.lastname: Verduijn
authors.forename: Dave L
authors.initials: DL
authors.lastname: Roelen
authors.forename: Stefan
authors.initials: S
authors.lastname: Böhringer
authors.forename: Tom W J
authors.initials: TW
authors.lastname: Huizinga
authors.forename: Désirée M
authors.initials: DM
authors.lastname: van der Heijde
authors.forename: René E M
authors.initials: RE
authors.lastname: Toes
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D015331:Cohort Studies; D004843:Epistasis, Genetic / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D015235:HLA-B Antigens / Q000235:genetics*; D015796:HLA-B27 Antigen / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000235:genetics*; D055815:Young Adult
chemical_list: D015235:HLA-B Antigens; D015796:HLA-B27 Antigen; C081918:HLA-B60 antigen